Archive:
In the cover interview: Prof. Dr. Juliane Köberlein Neu, Congress President of the 23rd German Congress for Health Services Research
03.08.2024
Das Ministerium für Soziales, Gesundheit, Integration und Verbraucherschutz des Landes Brandenburg (MSGIV) hat die Wirtschaftsförderung Land Brandenburg GmbH (WFBB) beauftragt, grundsätzliche Bedarfsanalysen für die fünf Versorgungsregionen des Landes Brandenburg durchzuführen. Das IGES Institut wurde zusammen mit AGENON Ende September 2023 mit dem Projekt „Erstellung von Versorgungsbedarfsanalysen für die Gesundheitsregionen Brandenburgs sowie Initiierung, Organisation und inhaltliche Begleitung von regionalen Dialogforen und Projektgruppen an jeweils unterschiedlichen Krankenhausstandorten“ beauftragt. Nun liegen erste Studienberichte vor. Die Projektpartner stellen diese vor.
03.08.2024
Nahezu alle Fachleute sind sich darüber einig, dass das deutsche Gesundheitssystem an seine Grenzen gestoßen ist und umfassend überarbeitet werden muss. Zwar geben Versicherte und Steuerzahler sehr viel Geld für Gesundheitsversorgung aus, erhalten dafür aber nicht immer entsprechende Spitzenleistungen. Und das, obwohl im Gesundheitssystem hochkompetente Leistungserbringer tätig sind und in weiten Bereichen leistungsfähige Einrichtungen und Strukturen bereitstehen. Dem stehen Leistungsbremsen gegenüber, die in verschiedenen Bereichen Dysfunktionalitäten mit teil-weise gravierenden Folgen erzeugen: unzureichende Kompromissfähigkeit zwischen Bundes- und Landespolitik, dysfunktionale Sektorierung, Diskrepanzen zwischen Angebot und Bedarf, Wettstreit zwischen Qualität und Ökonomie und über allem steht als Gipfel die mangelhafte Beteiligung der Patienten/Versicherten – sie finanzieren schließlich das Gesundheitssystem! Dieser Artikel geht über die Beschreibungen der aktuellen Situation hinaus und versucht zu analysieren, warum es Deutschland nicht gelingt, die sehr guten inhaltlichen und strukturellen Voraussetzungen in ein modernes, leistungs- und lernfähiges Gesundheitssystem zu übersetzen.
03.08.2024
Commentary by Dipl.-Soz. Maren Ewald BA, Director StattHaus Offenbach, Hans and Ilse Breuer Foundation
03.06.2024
Episode 16 of the commentary series: "Corona and Politics: On the Role of Science" by Prof. Dr. Klaus Püschel, former Director of the Institute of Forensic Medicine at the University Medical Center Hamburg-Eppendorf
03.06.2024
Episode 15 of the commentary series: "Corona and Politics: On the Role of Science" by Univ.-Prof. Mag. Dr. rer. nat. Willibald Stronegger, Institute of Social Medicine and Epidemiology, Medical University of Graz
03.06.2024
To achieve the vaccination recommendations of the WHO, STIKO, and SIKO, Germany needs the next step. It has become clear at the vaccination conferences held so far by "Monitor Versorgungsforschung": So far, the voluntary approach by healthcare stakeholders has not achieved what was hoped for. Otherwise, the actual vaccination rates would be higher. While they vary regionally, they have one thing in common: they are far too low. What needs to be done? Who is responsible? Who will assume a coordinating role? How can we do things better? This was the topic of the 6th MVF Vaccination Conference, entitled "Vaccination Pact for Germany."
03.06.2024
"Every study has limitations," Prof. Dr. med. Jochen Schmitt of the Center for Evidence-Based Health Care (ZEGV) and one of the main leaders of the WiZen study group (1) told "Monitor Gesundheitsforschung" (Monitor Health Services Research). Anyone who claims that health care studies exist without limitations has failed to understand the fundamentals of scientific work. Therefore, an important part of every scientific study is the discussion of the results, which includes a discussion of the methodological strengths, but also of any potential limitations, as was done extensively in the original publication of the WiZen study in the "Deutsches Ärzteblatt" (2). It is all the more surprising that Prof. Josef Hecken, impartial chairman of the Federal Joint Committee (G-BA) and chairman of the G-BA's Innovation Committee, addressed – Hecken's quote – "one or two methodological weaknesses" of the WiZen project on "Effectiveness of Care in Oncology Centers" (3), funded by the Innovation Fund, in his opening speech at the conference "The Innovation Fund: Between Sustainability and Further Development" (see p. 16 ff.). MVF conducts the fact check.
03.06.2024
643 projects were funded, including 230 projects in new forms of care and 413 projects in health services research, including guideline development projects. €1.25 billion was invested in new forms of care projects and €450 million in health services research projects. Looking at the hard figures for the Innovation Fund, which were presented at the conference "The Innovation Fund: Between Stabilization and Further Development," the fund is certainly a success story, having been transferred from "temporary" to "permanent" status with the Digitalization Act passed by the Bundestag at the end of 2023. The transition worked in this case, but less so for many of the Innovation Fund's projects themselves. There is a need for action here, as the stakeholders involved, especially the Chairman of the Federal Joint Committee (G-BA) and the Innovation Committee, Prof. Josef Hecken, are aware.
03.06.2024
The Spreestadt Forum is an interdisciplinary lecture series with changing topics. Organized and academically led by TU professors Busse and Kersting, the event takes place every semester. This year's guest was Prof. Josef Hecken, the impartial chairman of the Federal Joint Committee, who spoke on "On the Necessity of Structural Reforms in the Health Care System" and offered a more than emphatic take on the current hospital reform. His wish: "I would prefer no law at the moment to any law." Busse added: "I do too, to be honest."